Effect of Sacubitril/Valsartan vs Valsartan on Left Atrial Volume in Patients With Pre–Heart Failure With Preserved Ejection Fraction

Autor: Ledwidge, Mark, Dodd, Jonathan D, Ryan, Fiona, Sweeney, Claire, McDonald, Katherine, Fox, Rebecca, Shorten, Elizabeth, Zhou, Shuaiwei, Watson, Chris, Gallagher, Joseph, McVeigh, Niall, Murphy, David J, McDonald, Kenneth

Publikováno v: Ledwidge, M, Dodd, J D, Ryan, F, Sweeney, C, McDonald, K, Fox, R, Shorten, E, Zhou, S, Watson, C, Gallagher, J, McVeigh, N, Murphy, D J & McDonald, K 2023, ' Effect of Sacubitril/Valsartan vs valsartan on left atrial volume in patients with pre-heart failure with preserved ejection fraction: the parable randomized clinical trial ', JAMA cardiology . https://doi.org/10.1001/jamacardio.2023.0065

ImportancePre–heart failure with preserved ejection fraction (pre-HFpEF) is common and has no specific therapy aside from cardiovascular risk factor management.ObjectiveTo investigate the hypothesis that sacubitril/valsartan vs valsartan would redu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9ca4eb9ef510f0950d3f8003e5d3c28
https://doi.org/10.1001/jamacardio.2023.0065